Results 221 to 230 of about 13,261 (250)
Some of the next articles are maybe not open access.
Chronic inflammatory demyelinating polyneuropathy and diabetes
Journal of Neurology, Neurosurgery & Psychiatry, 2020CIDP is a most common chronic immune-mediated demyelinating neuropathy, but still a rare disease; the reported prevalence ranges from 0.8 to 8.9 per 100 000 people.1 The different prevalence among the studies is partly dependent on diagnostic criteria and CIDP subtypes.
Satoshi Kuwabara +2 more
openaire +2 more sources
Atypical chronic inflammatory demyelinating polyneuropathies [PDF]
Journal of Neurology, Neurosurgery & Psychiatry, 2018 Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-mediated neuropathy progressive for more than 2 months, including several clinical subtypes.1 2 In 1975, Dyck et al 3 described the classical prototype of CIDP, and emphasised that a prominent clinical feature is weakness of the proximal and distal muscles about equally which is very
Satoshi Kuwabara +2 more
openaire +2 more sources
Chronic inflammatory demyelinative polyneuropathy
2013Chronic inflammatory demyelinative polyneuropathy (CIDP) is an acquired polyneuropathy presumably of immunological origin. It is characterized by a progressive or a relapsing course with predominant motor deficit. The diagnosis rests on the association of non-length-dependent predominantly motor deficit following a progressive or a relapsing course ...
Said, Gérard, Krarup, Christian
openaire +4 more sources
Chronic inflammatory demyelinating polyneuropathy
Current Opinion in Neurology, 2007Purpose of review As a syndrome with typical and atypical cases, chronic inflammatory demyelinating polyneuropathy (CIDP) has been a difficult disorder to diagnose and treat. The pathophysiologic basis for CIDP has not been established, contributing to the challenges in dealing with these patients.
openaire +5 more sources
Chronisch inflammatorische demyelinisierende Polyneuropathie
Der Nervenarzt, 2003Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired immune-mediated disease of the peripheral nervous system with a prevalence of 1-2/100,000. Clinical and experimental findings suggest a role of immune pathomechanisms;however, the target antigens are still unknown.
Hans-Peter Hartung +3 more
openaire +5 more sources
Treatment of chronic inflammatory demyelinating polyneuropathy
The Italian Journal of Neurological Sciences, 1998The management of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is the main topic of this review. A few comments will also be made about treatment of the demyelinating form of paraproteinaemic demyelinating polyneuropathy (PDN) and of multifocal motor neuropathy (MMN).
COMI , GIANCARLO, ROVERI L.
openaire +4 more sources
Treatment of chronic inflammatory demyelinating polyneuropathy
Muscle & Nerve, 2022AbstractChronic inflammatory demyelinating polyneuropathy (CIDP) is a chronic peripheral polyneuropathy that results in disability through immune‐mediated nerve injury, but which not uncommonly has residual and irreversible neurological deficits after the active inflammatory component of the disorder has been treated.
Jeffrey A. Allen, Richard A. Lewis
openaire +2 more sources
Treatment of chronic inflammatory demyelinating polyneuropathy
Current Opinion in Neurology, 2004Chronic inflammatory demyelinating poly(radiculo)neuropathy (CIDP) is a treatable disorder. There are three proven effective treatments available. Randomized controlled trials have only focused on short-term effects, but most patients need long-term therapy. The most up-to-date treatment options are discussed.
Liselotte Ruts, Pieter A. van Doorn
openaire +3 more sources
The spectrum of chronic inflammatory demyelinating polyneuropathy
Journal of the Neurological Sciences, 2000Research criteria for the diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP) were proposed by an Ad Hoc Subcommittee of the American Academy of Neurology (AAN) in 1991, and since then these criteria have been widely used in clinical studies.
Khema Sharma +5 more
openaire +3 more sources
Fatigue in chronic inflammatory demyelinating polyneuropathy
Muscle & Nerve, 2020AbstractIntroductionIn this study we aimed to better understand fatigue in chronic inflammatory demyelinating polyneuropathy (CIDP) as it relates to disease activity status.MethodsPatients with probable or definite CIDP were stratified into active CIDP or CIDP in remission.
Jeffrey A. Allen +3 more
openaire +3 more sources